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The fibrillins and latent transforming growth factor-
b binding proteins (LTBPs) form a superfamily of
structurally-related proteins consisting of calcium-
binding epidermal growth factor-like (cbEGF)
domains interspersed with 8-cysteine-containing
transforming growth factor b-binding protein-like
(TB) and hybrid (hyb) domains. Fibrillins are themajor
components of the extracellular 10–12 nm diameter
microfibrils, which mediate a variety of cell-matrix
interactions. Here we present the crystal structure of
a fibrillin-1 cbEGF9-hyb2-cbEGF10 fragment, solved
to 1.8 A˚ resolution. The hybrid domain fold is similar,
but not identical, to the TB domain fold seen in
previous fibrillin-1 and LTBP-1 fragments. Pairwise
interactions with neighboring cbEGF domains
demonstrate extensive interfaces, with the hyb2-
cbEGF10 interfacedependent onCa2+binding. These
observationsprovideaccurateconstraints formodels
of fibrillin organization within the 10–12 nm microfi-
brils and provide further molecular insights into how
Ca2+ binding influences the intermolecular interac-
tions and biomechanical properties of fibrillin-1.
INTRODUCTION
The 10–12 nm fibrillin microfibrils of the extracellular matrix play
important roles in both elastic and nonelastic tissues. During
elastogenesis, they provide a scaffold for the deposition of tro-
poelastin and form the periphery of the mature elastic fiber. In
nonelastic tissues, such as the ciliary zonule of the eye and at
basement membranes, they have an anchoring function and
provide tissues with tensile strength (Kumaratilake et al., 1989).
In addition to these biomechanical functions, the microfibrils
are also involved in the regulation of growth factors through
the interactions of their major component, the fibrillins, with the
latent transforming growth factor-b binding proteins (LTBPs)
and bone morphogenetic proteins (Chaudhry et al., 2007; Greg-
ory et al., 2005; Isogai et al., 2003; Neptune et al., 2003; Sengle
et al., 2008). They also interact with a variety of other cell-matrix
components. The importance of these interactions is seen in the
development of diseases, such as Marfan syndrome, in which
mutations in fibrillin-1 lead to a loss of structural integrity in theStructure 17extracellular matrix and perturbations in transforming growth
factor b (TGF-b) signaling (Ramirez and Dietz, 2007).
Although it has been known for several years that fibrillin is the
main structural component of the microfibrils (Sakai et al., 1986),
the precise organization of individual fibrillin molecules within the
microfibrils is still controversial. When viewed by rotary shadow-
ing electron microscopy, microfibrils appear as beaded fila-
ments with an interbead distance of 56 nm. Several models
have been proposed to explain the organization of fibrillin into
microfibrils based on methods such as small-angle X-ray scat-
tering (SAXS) and multiangle laser light scattering (Baldock
et al., 2001, 2006), antibody labeling of extracted microfibrils
(Kuo et al., 2007; Reinhardt et al., 1996), mapping of proteolytic
cleavage sites (Kuo et al., 2007), and structure determination of
fibrillin fragments by nuclear magnetic resonance (NMR) and
X-ray crystallography (Knott et al., 1996; Lee et al., 2004; Small-
ridge et al., 2003). These models can be placed into two broad
groups: those in which fibrillin monomers are ‘‘folded’’ to fit
within one microfibril interbead distance (Baldock et al., 2001,
2006) and staggered models with extended fibrillin monomers
(Kuo et al., 2007; Lee et al., 2004).
The molecular organization of the fibrillins, and the related
LTBPs, is dominated by calcium-binding epidermal growth
factor-like (cbEGF) domains (Figure 1). These are interspersed by
transforming growth factor-b binding protein-like (TB) domains
throughout the polypeptides. Related domains, the hybrid (hyb)
domains, which have sequences similar to both the TB and
cbEGF domains, are found near the N termini of these mole-
cules, with two being found in each of the fibrillins (Corson
et al., 2004; Pereira et al., 1993; Zhang et al., 1994), and one
in each of the LTBPs (Gibson et al., 1995; Giltay et al., 1997;
Kanzaki et al., 1990; Yin et al., 1995). The fibrillin-1 hyb domains
have recently been shown to play a role in the structural integrity
of the microfibrils (Mellody et al., 2006) and to be involved in
interactions with other extracellular matrix proteins (El-Hallous
et al., 2007). The formation of intermolecular disulphide bonds
involving a conserved extra cysteine in domain hyb1 has been
suggested as an early part of the microfibril assembly process
(Reinhardt et al., 2000). Although there are significant sequence
similarities between the hyb and TB domains, there have been no
high-resolution data available for the structure of hyb domains or
for their interactions with adjacent domains. This information is
required to provide constraints on models for the arrangement
of fibrillin in the microfibrils and to understand the spatial
arrangement of cell-matrix molecules that interact with these
domain types., 759–768, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 759
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Fibrillin Hybrid Domain StructureHere we present the X-ray crystal structure of a cbEGF9-hyb2-
cbEGF10 triple domain fragment from fibrillin-1, providing the
first high-resolution structure of a hyb domain found in the fibril-
lin/LTBP protein family. We show that these highly disulphide-
bonded domains are structurally related to both the TB and
EGF domains, as suggested by previous sequence data (Corson
et al., 1993; Pereira et al., 1993), with an N-terminal region con-
taining a hydrophobic core consisting of a conserved tryptophan
as in the TB domains (Lee et al., 2004; Yuan et al., 1997), and the
C-terminal region containing a disulphide-stabilized b sheet
similar to some EGF domains (Knott et al., 1996). Measurements
of Ca2+ binding by both of the fibrillin-1 hyb-cbEGF domain pairs
show that the cbEGF domains in this context bind with high
affinity, with Kd values in the low nanomolar range. As in the
Figure 1. Domain Organization of Human Fibrillin-1
The fibrillin sequence is largely dominated by cbEGF domains, interspersed
with TB and hyb domains. Constructs used to determine Ca2+ affinities of
hyb-cbEGF pairs and the cbEGF9-hyb2-cbEGF10 construct are shown above
the figure.760 Structure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All righcase of TB-cbEGF domain pairs, this is due to interdomain
hydrophobic interactions stabilizing the Ca2+ binding pocket of
the cbEGF domain. These data can be used to extend our knowl-
edge of fibrillin structure and provide new constraints for models
of microfibril organization.
RESULTS
cbEGF9-hyb2-cbEGF10 and cbEGF22-TB4-cbEGF23
Constructs of Fibrillin-1 Have a Similar Shape
To characterize fully the architecture and interdomain interac-
tions of the hyb-2 domain and its adjacent cbEGF domains,
a crystal structure of the fibrillin-1 construct cbEGF9-hyb2-
cbEGF10 (Figure 1) was determined. Crystals were grown in
the presence of 20 mM CaCl2 in order to saturate the N-terminal
cbEGF9 Ca2+ binding site, which is likely to have a relatively low
affinity for Ca2+ based on previous work (McGettrick et al., 2000;
Smallridge et al., 1999, 2003). Crystals diffracted X-rays to high
resolution (1.7 A˚ for synchrotron data and 2.2 A˚ for in-house
data used for sulfur single wavelength anomalous dispersion
[SAD]) and belonged to space group P212121 (Table 1). Initial
phases were determined experimentally by a combination of
sulfur SAD and anomalous signals from bound Ca2+ (E.D.
Lowe, S.A. Jensen, P.A. Handford, V. Achard, and E.F. Garman,
unpublished data).
The overall shape of cbEGF9-hyb2-cbEGF10 (Figure 2A)
resembled the tetragonal pyramidal shape previously seen in
the fibrillin-1 cbEGF22-TB4-cbEGF23 structure (Lee et al.,
2004), with slightly smaller dimensions of approximately 6.5 3
3.5 3 2.5 nm. Like the TB4 fragment, extensive interdomainTable 1. Data Collection and Refinement Statistics
Data Collection
X-ray source ESRF ID23.EH1 In-house
Space group P212121 P212121
Unit cell dimensions (a, b, c) (A˚) (a, b, g) () 31.30, 47.63, 89.36, 90, 90, 90 31.232, 47.258, 89.105, 90, 90, 90
Molecules in the asymmetric unit 1 1
Resolution range (outer shell) (A˚)a 29.79-1.70 (1.79-1.70) 89.10-2.20 (2.30-2.20)
Number of reflections 15,382 12,682
Completeness (%)a 100.0 (100.0) 99.8 (99.0)
Multiplicitya 13.3 (13.7) 38.09 (17.63)
I/s (I)a 24.3 (7.6) 27.24 (5.66)
Rpim 0.026 (0.132)
Rsigma
a,b 0.0302 (0.1879)
Refinement Statistics
Rworking (%) 18.51
Rfree (%) 22.12
Solvent content 42.07
Average B factors (A˚2) 23.78
Average B factors for Ca2+ (A˚2) 17.31
Rmsd from ideal values
Bond lengths (A˚) 0.006
Bond angles () 1.027
a Values in parentheses correspond to the highest-resolution shell.
b Rsigma =
P½sðF20 Þ=
P ½F20 ts reserved
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Fibrillin Hybrid Domain Structurecontacts were observed between cbEGF9 and hyb2, and
between hyb2 and cbEGF10. As expected, both of the cbEGF
domains in the structure were found to contain bound Ca2+. In
cbEGF9, Ca2+ was coordinated by three side-chain oxygens
(Asp807, Glu810, and Asn823), three main-chain carbonyls
(Ile808, Ser824, and Ser827), and a single water molecule (Fig-
ure 2B). Coordination of the Ca2+ in cbEGF10 was through inter-
actions with three side-chain oxygens (Asp910, Glu913, and
Asn928), three main-chain carbonyls (Ile911, Thr929, and
Ser932), and a single water molecule (Figure 2C). In both cases
the Ca2+ ligands, from highly conserved residues involved in
Ca2+ binding in previously determined structures (Abbott et al.,
2007; Cordle et al., 2008; Lee et al., 2004; Rao et al., 1995) were
arranged with approximate pentagonal bipyramidal geometry.
A superposition of the cbEGF9-hyb2-cbEGF10 structure onto
cbEGF22-TB4-cbEGF23 highlighted the high degree of similarity
between the structures (Figure 3A). The relatively high root-
mean-square deviation (rmsd) value derived from the superposi-
tion (2.96 A˚) was likely due to small differences in domain
packing. Superpositions of the individual domains cbEGF9,
hyb2 and cbEGF10 structure onto the corresponding domains
in cbEGF22-TB4-cbEGF23 (Figure 3B) showed higher degrees
of similarity (rmsd = 0.829, 1.844, and 1.668, respectively),
consistent with the conserved nature of the cbEGF fold and
similarities between TB and hyb domain sequences.
Figure 2. Crystal Structure of Fibrillin-1
cbEGF9-hyb2-cbEGF10
Crystals were grown in the presence of 20 mM
CaCl2 to saturate the Ca
2+ binding sites of both
cbEGF domains. The cbEGF domains are shown
in green and the hyb2 domain in magenta. Ca2+
bound to the cbEGF domains is represented by
red spheres and disulphide bonds are shown
in yellow. (A) Views either down the molecule
(N terminus view) or from above the molecule
(top view) show the overall linear arrangement of
the domains. Ca2+ coordination in cbEGF9 (B)
and cbEGF10 (C) was through conserved back-
bone and side-chain interactions as seen in previ-
ously determined structures (Abbott et al., 2007;
Cordle et al., 2008; Lee et al., 2004; Rao et al.,
1995).
DomainHyb2Has aTBDomain-Like
Fold with a Rearrangement
of Disulphides
The hyb2 domain structure is similar to the
previously determined TB domain struc-
tures (Lack et al., 2003; Lee et al., 2004;
Yuan et al., 1997) (Figures 3C and 3D).
Both domain types have a central a helix,
containing the Cys-Cys-Cys motif of the
TB domain and Cys-Cys dipeptide of the
hyb domain (Figures 3C and 3D). Similar
stretches of b sheet are also seen in
both domain types, with a three- or four-
stranded section near the N-terminal half
of the domain and a two-stranded section
of b sheet near the C terminus. A
conserved cis-proline (Pro886) is also seen in the hyb2 domain
in the position corresponding to the cis-proline observed previ-
ously in the TB4 structure (Pro1573) (Lee et al., 2004). The major
secondary structural difference between the two domain types is
the absence of a second stretch of a helix in the hybrid domain
(indicated by an arrow in Figure 3C).
In both the TB and hyb domains, the first two of the cysteines
(C3 and C4) in the central a helix form disulphide bonds with
cysteines toward the N-terminal part of the domain near the
hydrophobic core. In the TB domains, a third disulphide is
formed between C5 in the central a helix and C8, which is posi-
tioned between the second a helix and the final two strands of
b sheet. The hyb2 structure shows a rearrangement of disul-
phides toward the C-terminal part of the domain so that the
cysteine corresponding to C8 in the TB domain forms a disul-
phide bond with the second to last residue of the domain. This
is likely to stabilize the C-terminal b sheet of the hyb domain
and changes the arrangement of disulphides from C1-3, 2-6,
4-7, 5-8 in the TB domains to C1-3, 2-5, 4-6, 7-8 in the hyb
domain (Figure 3E).
Hyb2 Forms Extensive Contacts with Adjacent cbEGF
Domains in the Presence of Ca2+
An understanding of how adjacent domains in fibrillin interact is
required to provide important constraints on how individualStructure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 761
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Fibrillin Hybrid Domain StructureFigure 3. Comparison of Hyb2 and TB4
Domain Structures
(A) Superposition of cbEGF9-hyb2-cbEGF10 onto
the previously determined structure of fibrillin-1
fragment cbEGF22-TB4_cbEGF23 (Lee et al.,
2004) showing the overall similarity of the struc-
tures.
(B) Superpostion of individual domains of
cbEGF9-hyb2-cbEGF10 onto the corresponding
regions of cbEGF22-TB4-cbEGF23 indicated
that differences in the structures were largely
due to small differences seen in the interdomain
packing interactions of the different constructs.
(C and D) Domain hyb2 (C) has secondary struc-
ture elements similar to those seen in TB4 (D)
(Lee et al., 2004). A conserved tryptophan (cyan
spheres in the 3D models) is involved in forming
the hydrophobic core of each domain. The arrow
in (C) highlights the loss of an a helix in hyb2 rela-
tive to the corresponding position in TB4.
(E) Comparison of the TB4 and hyb2 domain
sequences with the disulphide bond pairings in
each indicated. The rearrangement of disulphides
in hyb2 compared with TB4 results in the stabiliza-
tion of a C-terminal b sheet in the hyb2 domain (red
bracket).fibrillin molecules can be arranged within the microfibril. Previous
studies have shown that Ca2+ plays an important role in the
formation of interfaces within cbEGF-cbEGF and TB-cbEGF
pairs, and confers a rigidity to these structures (Jensen et al.,
2005; Kettle et al., 1999; Knott et al., 1996; Smallridge et al.,
1999; Whiteman et al., 1998). To examine the interactions of
domain hyb2, points of contact at the interdomain interfaces
and buried surface areas of cbEGF9-hyb2-cbEGF10 were deter-
mined from the crystal structure using the programs Contact and
AreaIMol in the CCP4 program suite (CCP4, 1994). Using a 4.0 A˚
maximum contact distance, residues in hyb2 found to interact
with parts of cbEGF9 included Thr848, Ile849, Ser873, and
Arg902 (Figure 4A). At the other side of the hyb2 domain, resi-
dues Ile866, Asn867, Ser877, Leu879, Gly899, and Tyr900
were found to be involved in interdomain contacts with cbEGF10
residues (Figure 4B). A comparison of the residues in hyb2 and
TB4 that interact with the adjacent cbEGF domains (Figure 4C)
shows that there are conserved patches of sequence that are
involved in packing with either the N-terminal or C-terminal adja-
cent domain.
At the cbEGF9-hyb2 interface, the buried surface area was
451.1 A˚2, averaged between the two surfaces, and the corre-
sponding value for the hyb2-cbEGF10 interface was 552.3 A˚2.
The formation of interdomain interfaces is predicted to result in
approximately 20% of the available surface area of the individual
domains being buried. In comparison, the TB4-cbEGF23 inter-
face measured by Lee et al. (2004) was found to bury a surface
area of 670 A˚2, which is comparable to the 700 A˚2 typical of an
antibody-antigen interface (Colman, 1988). cbEGF-cbEGF
domain interfaces are typically less extensive, with buried
average surface areas of 220.15 A˚2 at the cbEGF12-cbEGF13
interface and 183.55 A˚2 at the cbEGF32-33 interface as762 Structure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All righmeasured using AreaIMol and previously determined structures
(Downing et al., 1996; Smallridge et al., 2003). Thus, the interac-
tions mediated by hyb and TB domains are likely to have a signif-
icant impact on the overall stability and shape of the fibrillin-1
molecule.
The ‘‘Hybrid’’ Nature of the Hyb Domain Sequence
Is Reflected in its Structure
Early sequencing data for FBN1 cDNA suggested that fibrillin-1
had unique hybrid domains with properties that were similar to
both the TB and EGF domains (Corson et al., 1993; Pereira
et al., 1993). An alignment of various TB and cbEGF domains
from fibrillin-1 with the hybrid domains of fibrillin-1 and the
LTBPs (Figures 5A–5C) shows these similarities. The fibrillin
and LTBP hybrid domain sequences share several conserved
features including the positions of 8 cysteine residues,
a conserved aromatic residue at the N terminus of the domain,
a central Gly-x-x-Trp-Gly sequence, and a Gly-Phe/Tyr dipep-
tide at the C terminus. A comparison of the hybrid domains
with the TB domains of fibrillin-1 shows that they share similar
features at their N-terminal ends, with the exception of the
Cys-Cys-Cys sequence in the TB domain being replaced with
a Cys-Cys dipeptide in the hyb domains.
Conservation of the N-terminal aromatic and a central
Gly-x-x-Trp-Gly sequence that forms a hydrophobic core in TB
domains (Lack et al., 2003; Lee et al., 2004; Yuan et al., 1997)
suggests structural similarities between these domain types
(Figure 5D). The C-terminal end of the hyb domain resembles
the sequence found at the C-terminal end of the cbEGF
sequences of fibrillin-1, with closely related sequence lengths
and conservation of a Gly-Phe/Tyr dipeptide that is involved in
interdomain interactions in cbEGF tandem repeats. Thesets reserved
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Fibrillin Hybrid Domain Structurestructural observations are consistent with a mechanism for the
evolution of the hyb domain from a TB-cbEGF pair.
Hyb-cbEGF Domain Pairs Have a High Ca2+ Affinity
A previous study of the Ca2+ binding properties of TB-cbEGF
pairs showed that Ca2+ affinity was strongly influenced by the
presence of a hydrophobic interdomain interface. The parts of
the cbEGF domain found experimentally to be involved in this
interaction were the X-Gly interdomain packing site in the central
b sheet of the domain, and the ‘‘loop 1’’ sequence (Figure 5C)
found between C1 and C2 of the cbEGF domain (Jensen et al.,
2005). A comparison of the cbEGF domains in the fibrillin-1
hyb1-cbEGF1 and hyb2-cbEGF10 pairs with those found in
high Ca2+ affinity domain pairs TB4-cbEGF23, TB5-cbEGF25,
and TB7-cbEGF37 shows similarities in these regions
(Figure 5C). The loop 1 sequences of cbEGF1 (CQAIPGLC) and
cbEGF10 (CEVFPGVC) have similar hydrophobic character to
the loop 1 sequence of cbEGF23 (CQELPGLC), which is involved
in hydrophobic interactions with domain TB4 and makes a signif-
icant contribution to the high Ca2+ affinity of the TB4-cbEGF23
domain pair. The presence of a Gly-Phe/Tyr dipeptide at
the C-terminal end of the hyb domains, in a position similar to the
conserved Gly-Phe/Tyr interdomain packing site found in the
N-terminal domain of cbEGF-cbEGF pairs, suggested another
potential site of hyb-cbEGF interdomain packing. We therefore
predicted that the fibrillin-1 hyb-cbEGF domains would be sites
of high Ca2+ affinity based on our previous TB-cbEGF data.
Figure 4. Residues Involved in the Forma-
tion of Interdomain Interfaces
(A and B) Residues involved in interdomain
contacts were identified using the program
Contact in the CCP4 program suite (CCP4, 1994),
with a distance limit of 4 A˚. Hyb domain residues
at the cbEGF9-hyb2 interface (A) or hyb2-cbEGF10
interface (B) are indicated by magenta spheres and
interacting cbEGF residues are indicated by green
spheres.
(C) An alignment of the hyb2 and TB4 domains
shows similarities of the regions involved in interac-
tions with either the N-terminal (red) or C-terminal
(cyan) cbEGFs. Domains were aligned using Clus-
tal W 2.0 (Larkin et al., 2007), and cysteines are
highlighted in yellow.
Assays of the hyb2-cbEGF10 pair with
the chromophoric Ca2+ chelator Quin-2
(Table 2; see Figure S1 available online)
showed that this domain pair bound
with very high affinity, with a Kd value of
14.7 ± 3.7 nM (mean ± standard deviation
[SD], n = 4). In addition, the Ca2+ affinity of
a cbEGF9-hyb2-cbEGF10 construct
(Table 2; Figure S1) was measured using
Quin-2 to examine the effect of having an
extra domain at the N terminus of the hyb
domain. The measured Kd value for this
construct, 12.2 ± 4.0 nM (mean ± SD,
n = 5), suggested that the addition of
a cbEGF to the N terminus of the hyb2
domain had no significant effect on the Ca2+ affinity of cbEGF10,
and that the high Ca2+ affinity of this construct is due entirely to
hyb2-cbEGF10 interfacial interactions.
To test whether this was a general feature of the hyb-cbEGF
pairs, Ca2+ binding by the hyb1-cbEGF pair of fibrillin-1 was
studied. Chelation competition assays of the native hyb1-
cbEGF1 domain pair were not possible due to the insolubility
of this fragment. Not unexpectedly, this insolubility was found
to be due to the presence of a free thiol, as determined by assays
with Ellman’s reagent (data not shown), which became reactive
when the protein was dissolved in buffers at physiological pH.
Ca2+ binding was therefore measured for a hyb1-cbEGF1
construct containing a Cys204Ser substitution, which removed
the free thiol previously shown to be involved in intermolecular
interactions (Reinhardt et al., 2000). Assays of hyb1-cbEGF1
(Cys204Ser) with Quin-2 (Table 2; Figure S1) showed that this
construct had a very high Ca2+ affinity, with a Kd value of 8.7 ±
3.5 nM (mean ± SD, n = 4). Molecular modeling of hyb1, based
on the hyb2 structure, shows that the extra cysteine of hyb1 is
likely to be positioned at the N terminus of the central a helix of
the domain in a solvent-exposed position (Figure 6A).
NMR analysis of the hyb2-cbEGF10 domain pair, using 2D
nuclear Overhauser enhancement spectroscopy (NOESY) and
heteronuclear single quantum coherence (HSQC) spectra of
15N-labeled material, and assignments based on 3D HSQC-
NOESY and HSQC/total correlation spectroscopy data in the
presence of 5 mM Ca2+ or 10 mM EDTA, showed that significantStructure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 763
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Fibrillin Hybrid Domain Structureconformational changes occurred on Ca2+ binding in solution
(data not shown; S.A.J., S.I., E.D.L., C.R., and P.A.H., unpub-
lished data). Chemical shift changes were seen for both cbEGF
and hyb domain residues, indicating that interface formation in
the hyb2-cbEGF10 pair is Ca2+-dependent as seen previously
in TB-cbEGF domain pairs (Jensen et al., 2005).
Molecular Modeling of Domains cbEGF7-cbEGF13
Suggests a Near-Linear Arrangement
The structure presented here indicates that, under physiological
Ca2+ concentrations (1.5 mM free Ca2+), the region around
hyb2 would be near linear with N and C termini emerging at
opposite ends of the fragment. Based on our current knowledge
of cbEGF, TB, and hyb domain structures (Lack et al., 2003; Rao
et al., 1995; Smallridge et al., 2003; Yuan et al., 1997), and of
cbEGF-cbEGF (Downing et al., 1996; Knott et al., 1996), TB-
cbEGF (Jensen et al., 2005; Lee et al., 2004), and hyb-cbEGF in-
terdomain interactions, we can now produce molecular models
of most of the fibrillin molecule. Using high-resolution structural
data and an understanding of interactions that occur at interdo-
main interfaces, we propose that fibrillin monomers form largely
extended structures, at least between domains cbEGF3 and
cbEGF43. This is consistent with several electron microscopic
studies of fibrillin monomers and recombinant fragments (Hub-
macher et al., 2008; Lin et al., 2002; Reinhardt et al., 1997a).
The region around domain hyb2 is of particular interest because
Figure 5. Alignments of TB, Hybrid, and
cbEGF Domains
(A–C) TB domains from fibrillin-1 (A), hybrid
domains from fibrillin-1 (hyb1 and hyb2) and
LTBPs 1-4 (B), and the cbEGF domains found in fi-
brillin-1 hyb-cbEGF domain pairs and high Ca2+
affinity fibrillin-1 TB-cbEGF pairs (C) were aligned
using Clustal W 2.0 (Larkin et al., 2007). Cysteine
residues are highlighted in yellow. The positions
of the ‘‘loop 1’’ and ‘‘X-Gly’’ interdomain packing
sites of the cbEGFs are indicated. Regions that
show a high degree of sequence conservation
between TB and hyb domains are highlighted
in cyan. The Gly-Phe/Tyr dipeptide found at the
C-terminal end of the domains, which has previ-
ously been shown to be involved in interdomain
interactions in TB-cbEGF pairs (Jensen et al.,
2005; Lee et al., 2004) and cbEGF-cbEGF pairs
(Knott et al., 1996; Smallridge et al., 2003), is high-
lighted in green.
(D) Comparison of the hyb2 domain structure with
the structures of cbEGF (green) and TB (blue)
domains mirrors the sequence alignment data
and confirms the ‘‘hybrid’’ nature of the domain.
The conserved Trp at the hydrophobic core of the
TB domain is shown as cyan spheres, and the con-
served aromatic found at the C-terminal packing
site of the cbEGF is shown as green spheres.
Table 2. Calcium Dissociation Constants Determined
by Competition with Quin-2
Fibrillin-1 Fragment Kd (nM)
a
hyb1-cbEGF1(C204S) 8.7 ± 3.5, n = 4
hyb2-cbEGF10 14.7 ± 3.7, n = 5
cbEGF9-hyb2-cbEGF10 12.2 ± 4.0, n = 4
a Values shown are mean ± SD.
it contains all three of these interface
types and is also at the beginning of the
‘‘neonatal’’ region of fibrillin affected by
mutations resulting in the neonatal
Marfan syndrome phenotype. Based on
domain structure and interface data, a model of the fibrillin-1
fragment spanning the region from cbEGF7-cbEGF13 (Figure 6B)
was produced. The results suggest a linear organization of the
region, with a slight twist in the region of hyb2 and TB3 in which
these two domains appear inverted with respect to each other.
DISCUSSION
Our study has provided the first high-resolution structure and
possible evolutionary origin of a hybrid domain, one of the major
disulphide-rich domains of the fibrillin/LTBP superfamily. Overall
the fibrillin-1 hyb2 domain has a globular shape, resembling a TB
domain, and is involved in extensive interactions with its neigh-
boring domains, cbEGF9 and cbEGF10. A mechanism for the
evolution of the hybrid domain as a fusion of TB and cbEGF
domains was first proposed by Pereira et al. (1993). They showed
that the N-terminal sequence of hyb2, encoded by exon 21, is764 Structure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All rights reserved
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Fibrillin Hybrid Domain Structurehomologous to the sequence encoded by the upstream exon of
a 2-exon TB domain and that the C-terminal part of domain hyb2,
encoded by exon 22, has a similar spacing between the cyste-
ines as the C-terminal third of a cbEGF domain. A comparison
of the structures of the hyb2, TB, and cbEGF domains indicates
that this similarity in sequences is conserved at the structural
level, suggesting that these domains arose from the fusion of
a TB-cbEGF pair (Figure 5D). The functional significance of the
rearrangement of disulphides in a hyb domain compared with
a TB domain is unclear. It has been proposed that the C-terminal
linker region of fibrillin domain TB4 could act as a molecular
spring (Lee et al., 2004), with application of a tensional force
causing unfolding of the C-terminal b-hairpin that could allow
the region to extend by up to 5 nm. This would not be possible
in a hybrid domain, with the C-terminal b-hairpin constrained
by a disulphide bond, but a different mechanism of extension
might be possible in this case. An unstructured loop between
C6 and C7 (890CQVDPIC896) of hyb2 separates the N-terminal
TB-like region from the C-terminal cbEGF-like region. Under
Figure 6. Models of Other Fibrillin-1
Regions
(A) A model of domain hyb1, using the coordinates
of hyb2 from the cbEGF9-hyb2-cbEGF10 struc-
ture, shows that Cys204 is likely to occur at an
exposed position at the N terminus of the
domain’s central a helix.
(B) Molecular modeling data suggest that the
region from cbEGF7 to cbEGF13 is generally
linear, with domains hyb2 and TB3 inverted with
respect to each other. Models were created using
Modeler software (Eswar et al., 2007) and the
coordinates of the structures determined for fibril-
lin-1 fragments cbEGF12-cbEGF13 (Smallridge
et al., 2003), cbEGF32-33 (Downing et al., 1996),
and cbEGF22-TB4-cbEGF23 (Lee et al., 2004).
(C) An earlier interpretation of the structure of the
cbEGF7-cbEGF13 region (i), based on SAXS
data (Baldock et al., 2006), suggested a V-shaped
bend in the region of the hyb domain. High-resolu-
tion studies of hyb and TB interactions with
adjacent domains (ii) suggest a more linear organi-
zation, highlighting the influence of high-resolution
constraints on models to explain microfibril length
and extensibility.
tension, this loop could allow the
disruption of the hyb-cbEGF interface,
extending the length of the structure by
approximately 3.5 nm. Recoil of the
system would be achieved by the refor-
mation of the hyb-cbEGF interface, which
is stabilized by the binding of Ca2+
binding to cbEGF10. Such dynamic
behavior could facilitate the structural
role of fibrillin in connective tissues that
are subjected to high tensional forces.
The organization of fibrillin in the 10–
12 nm diameter microfibrils is still a topic
of controversy, with several models
having been proposed based on a wide
range of experimental techniques (Baldock et al., 2001, 2006;
Knott et al., 1996; Kuo et al., 2007; Lee et al., 2004; Reinhardt
et al., 1996; Smallridge et al., 2003). An understanding of the
interdomain interactions within fibrillin is required for the devel-
opment of any model of microfibril organization. Binding of
calcium to the cbEGF domains rigidifies the structure of tandem
cbEGF repeats and has been shown to determine the shape of
fibrillin and protect it against proteolytic cleavage (Reinhardt
et al., 1997a, 1997b). High-resolution structures of cbEGF
domain pairs have shown that calcium binding to cbEGF
domains stabilizes hydrophobic interdomain contacts (Knott
et al., 1996; Smallridge et al., 2003). Solution and X-ray crystal
structures of a number of TB domain-containing fragments
(Lack et al., 2003; Lee et al., 2004; Yuan et al., 1997) have shown
that these domains are stabilized by disulphide bonds in a C1-3,
2-6, 4-7, 5-8 arrangement, and contain a conserved aromatic
residue that forms the hydrophobic core of the domain. In fibril-
lin-1, extensive interactions at cbEGF-TB and TB-cbEGF inter-
faces have been observed in an integrin-binding fragmentStructure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 765
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affinity of the TB4-cbEGF23 pair (Kd = 16 nM) in this fragment
was in contrast to previous observations of a TB6-cbEGF32 frag-
ment (Kd = 1.6 mM), suggesting that Ca
2+ affinities across the
molecule could vary substantially. This was found to be the
case in a study of all fibrillin-1 TB-cbEGF domain pairs, where it
was also shown that Ca2+ affinity could be correlated with the
degree of interdomain interaction. Given the relatively high affin-
ities seen for all the TB-cbEGF pairs except TB6-cbEGF32, it
was suggested that these regions of fibrillin form rigidified, linear
structures at Ca2+ concentrations found in the extracellular matrix
(Jensen et al., 2005).
The overall structure of the Ca2+-saturated fibrillin-1 cbEGF9-
hyb2-cbEGF10 fragment determined here generally resembles
the cbEGF22-TB4-cbEGF23 integrin-binding fragment des-
cribed previously (Lee et al., 2004), with extensive interdomain
interactions that are Ca2+-dependent at the hyb2-cbEGF10 inter-
face. As in the case of the TB4-cbEGF23 domain pair (Jensen
et al., 2005), the Ca2+ affinity of hyb2-cbEGF10 was found to be
much higher than would be required to reach saturation under
the Ca2+ concentrations found in the extracellular matrix. The
buried surface area at the hyb-cbEGF interface was slightly
less than the 670 A˚2 seen at the TB4-cbEGF23 interface (Lee
et al., 2004). The significance of these very high Ca2+ affinity sites
is not understood, but might be related to the proposed exten-
sible nature of the microfibrils in dynamic connective tissues.
Extensive hydrophobic interactions at hyb-cbEGF and TB-
cbEGF interfaces, stabilized by Ca2+, could provide the driving
force for recoil after the application of a tensile force. An extensive
protein-binding interface between hyb1 and cbEGF1, as sug-
gested by the high Ca2+ affinity observed for this domain pair,
would also explain the context-dependent interactions of domain
hyb1 with the fibulins seen by El-Hallous et al. (2007). Domain
hyb1, when placed in the position of domain hyb2, was unable
to ‘‘drive’’ the binding of recombinant fibrillin-1 fragments to fibu-
lins, suggesting that a specific molecular surface formed by the
interactions of hyb1 with its adjacent domains is required for
these intermolecular interactions.
Structural studies on fibrillin fragments are also highly relevant
to the closely related LTBPs, each of which contains one hyb
domain in the context of a hyb-cbEGF-TB fragment bordered
by relatively long stretches (89–148 residues) of cysteine-free
sequence. LTBPs 1, 3 and 4 have been shown to bind covalently
the latency-associated peptide of TGFb through the formation of
an intermolecular disulphide bond, with the interaction mediated
by the rearrangement of a disulphide bond in the second TB
domain of the LTBPs. The structural basis of this rearrangement
has been well-characterized and is due to the presence of a two
amino acid insertion between C6 and C7 of the TB domains,
leading to the increased solvent accessibility of the C2-C6 disul-
phide bond. In the fibrillin-1 hyb2 structure, no comparable
arrangement of disulphides was observed, suggesting that this
domain is unlikely to be involved in disulphide rearrangements.
In contrast, domain hyb1 has been shown to be involved in the
formation of intermolecular disulphides as a result of the pres-
ence of a conserved 9th cysteine (Reinhardt et al., 2000). Our
model of domain hyb1, based on the structure of hyb2 deter-
mined in the cbEGF9-hyb2-cbEGF10 structure, is consistent
with a surface-exposed position for Cys204, near the N-terminal766 Structure 17, 759–768, May 13, 2009 ª2009 Elsevier Ltd All righend of the central a helix of the domain (Figure 6A), and suggests
that both TB and hyb domains contain potential protein binding
surfaces distinct from their intramolecular interfaces.
A fibrillin fragment spanning from cbEGF7-cbEGF11 has
recently been studied by SAXS (Baldock et al., 2006). Rigid
body modeling to the SAXS data, using known cbEGF and TB
domain structures, produced a V-shaped structure with the
bend at the hyb domain (Figure 6C[i]), in contrast to the model
based on X-ray crystallographic data (Figure 6C[ii]). In these
previous studies, modeling of the hyb domain region was
possible only for the N-terminal region homologous to TB
domains, but without high-resolution structural data it would
not have been possible to model accurately the interaction of
hyb2 with the adjacent domains. The Ca2+-saturated cbEGF9-
hyb2-cbEGF10 structure presented in our study shows that
domains cbEGF9 and cbEGF10 pack against domain hyb2 to
form a near-linear structure. Ca2+ binding data for the hyb2-
cbEGF10 pair shows that an extensive interface is formed
between these domains, as seen previously in TB-cbEGF pairs
where specific hydrophobic contacts between domains were
found to influence Ca2+ affinity (Jensen et al., 2005). These differ-
ences in the observed and modeled hyb domain structures high-
light the importance of high-resolution data in the development
of models to explain the organization of fibrillin microfibrils.
Variations in the way domains pack against each other can
lead to substantial differences in the predicted dimensions and
shape of full-length fibrillin monomers (Figure 6C), which can
have a significant impact on how these data are used to model
microfibril organization. Although dissection approaches for
structure determination have limitations in that studies can be
time-consuming and might not detect long-range interactions
involving flexible regions, the identification of interdomain inter-
actions at atomic resolution provides an essential constraint
for microfibril modeling.
In summary, the data presented here extend our knowledge of
the structural properties of fibrillin-1 and provide further
evidence for an extended model of microfibril organization. In
addition, our data suggest a mechanism by which microfibril
extensibility could be achieved that does not disrupt potential
binding sites for microfibril accessory proteins.
EXPERIMENTAL PROCEDURES
Cloning and Expression of Fibrillin Constructs
All recombinant constructs were expressed in Escherichia coli strain BL21 as
His6-tagged fusion proteins using the pQE-30 expression vector (Qiagen).
Constructs corresponding to protein fragments hyb1-cbEGF1 (Arg179 to
Glu287), cbEGF9-cbEGF10 (Asp807 to Leu951), and hyb2-cbEGF10 (Glu847
to Leu951) were amplified from a human fibrillin-1 cDNA (Kettle et al., 2000)
using Pfu polymerase and cloned into the expression vector pQE-30 (Knott
et al., 1996). A Cys204Ser substitution was introduced into the hyb1-cbEGF1
construct, to produce hyb1-cbEGF1(C204S), by site-directed mutagenesis
using an overlapping polymerase chain reaction method as described previ-
ously (Jensen et al., 2005).
Expression, in vitro refolding and purification were essentially as described
(Knott et al., 1996) except in the case of hyb1-cbEGF1(C204S), for which
glycerol was added to 50% (v/v) to the refolding mixture to maintain protein
solubility. An additional dialysis step, against 0.1% (v/v) trifluoroacetic acid,
was added before high-performance liquid chromatography (HPLC) purifica-
tion of the refolding mixture in these cases to reduce the viscosity of the
solution.ts reserved
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Crystallization trials were carried out using solutions of cbEGF9-hyb2-
cbEGF10 prepared at 15 mg/ml in 20 mM CaCl2. Sparse matrix screening
and optimization produced rod-shaped crystals using a reservoir solution of
100 mM Tris (pH 7.5), 200 mM NaI, and 16% PEG 3350. All crystals were
washed with mother liquor supplemented with 25% (v/v) glycerol before
storage in liquid nitrogen. Native X-ray diffraction data were collected at the
European Synchrotron Radiation Facility (ESRF). Initial phases were deter-
mined from SAD data collected in-house using a Bruker MicroStar Smart
6000 CCD X-ray generator, with signals from both sulfur and calcium (E.D.
Lowe, S.A. Jensen, P.A. Handford, V. Achard, and E.F. Garman, unpublished
data). The structure was rebuilt and refined using Coot (Emsley and Cowtan,
2004) and phenix.refine (Adams et al., 2002) software.
Chromophoric Ca2+ Chelator Competition Assays
Ca2+ dissociation constants were determined by competition with the chromo-
phoric Ca2+ chelator Quin-2 as described previously (Linse et al., 1991). To
minimize background levels of Ca2+ in protein solutions, all proteins were
treated with 5 mM EDTA prior to purification by HPLC. Ca2+-free solutions of
proteins in Ca2+-free buffer (5 mM Tris, pH 7.5, 150 mM NaCl) were titrated
with Ca2+ stock buffer (5 mM Tris, pH 7.5, 150 mM NaCl, 1 mM CaCl2) in the
presence of Quin-2. All titrations were performed with 20 – 30 mM chelator
and 20 – 30 mM protein at 23 ± 2C using a Shimadzu UV mini 1240 spectro-
photometer to monitor absorbance at 263 nm. Background Ca2+ levels in
the protein-containing samples were determined by extrapolating the initial
linear region of each titration curve back to the y-axis. The initial Ca2+ concen-
tration of each curve was adjusted so that the y-intercept was equivalent to
that of a ‘‘chelator-only’’ control. The Kd value for Quin-2 was determined inde-
pendently from chelator only control experiments; a Kd value of 0.35 mM for
Quin-2 was obtained. Free Ca2+ concentration at each titration point was
calculated by the Newton-Raphson method, and dissociation constants
were calculated by least-squares fitting to the data, as described previously
using in-house software (Jensen et al., 2005; Linse et al., 1991; Stenberg
et al., 1997). Errors in the measured Kd values were estimated from at least
four repeats of each assay.
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